The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritisRiente, L. · Reumatismo · 2011

Anakinra in the treatment of rheumatoid arthritis and other IL-1-driven conditionsNordström, Dan C · Future Rheumatology · 2007

Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritisDaniel E. Furst · 2004

The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritisCohen, Stanley B · Rheumatic Disease Clinics of North America · 2004

Efficacy of the IL-1 receptor antagonist, anakinra, for the treatment of diffuse anterior scleritis in rheumatoid arthritis. Report of two casesBotsios, C.; Sfriso, P.; Ostuni, P. A.; Todesco, S.; Punzi, L. · Rheumatology · 2007

Combination therapy with etanercept and anakinra in the treatment of patients with rheumatoid arthritis who have been treated unsuccessfully with methotrexateMark C. Genovese; Stanley Cohen; Larry Moreland; Deborah Lium; Sean Robbins; Richard Newmark; Pirow Bekker; for the 20000223 Study Group · 2004

Results of anakinra treatment in rheumatoid arthritis patients previously treated with tumor necrosis factor α blockade: Comment on the article by Buch et alTore Saxne; Lotta Larsson; Pierre Geborek · 2004

Systematic review/Meta-analysis Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysisKawalec, Paweł; Paszulewicz, Anna; Holko, Przemysław; Pilc, Andrzej · Archives of Medical Science · 2012

Cost-utility analysis of Ruconest ® (conestat alfa) compared to Berinert® P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedemaKawalec, Paweł; Holko, Przemysław; Paszulewicz, Anna · Advances in Dermatology and Allergology · 2013